Paul Dunn, MD
Dermatology · Spokane Valley, WANPI 1386619294
Payments from drug & device makers
Across 1,031 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$5K
- AbbVie$4K
- E.r. Squibb & Sons, L.L.C.$4K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$3K
- Johnson & Johnson$3K
- Novartis$2K
- plus $7K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 110 | $4,892 |
| AbbVie(2 entities) | 227 | $4,114 |
| E.r. Squibb & Sons, L.L.C. | 50 | $3,668 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 39 | $3,406 |
| Johnson & Johnson | 158 | $2,913 |
| Novartis | 85 | $1,949 |
| Lilly USA, LLC | 86 | $1,614 |
| Arcutis Biotherapeutics, Inc. | 14 | $907 |
| Pfizer | 61 | $685 |
| Sun Pharmaceutical Industries Inc. | 30 | $592 |
| Amgen | 26 | $508 |
| Sanofi | 20 | $463 |
| Galderma Laboratories, L.p. | 38 | $431 |
| Regeneron Healthcare Solutions, Inc. | 18 | $400 |
| Dermavant Sciences, Inc. | 9 | $367 |
| Genentech USA, Inc. | 16 | $244 |
| Boehringer Ingelheim | 5 | $213 |
| LEO Pharma Inc. | 8 | $185 |
| Incyte Corporation | 9 | $173 |
| Eli Lilly | 1 | $99 |
| Bristol Myers Squibb | 3 | $62 |
| Biowound Solutions, Inc. | 2 | $56 |
| Almirall LLC | 2 | $50 |
| Prugen, Inc. Pharmaceuticals | 3 | $44 |
| Biofrontera Inc. | 2 | $37 |
| Nobelpharma America, LLC | 2 | $29 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $26 |
| Taro Pharmaceuticals USA, Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Organon | 1 | $14 |
How this compares
$28,210 in reported general payments places this provider in the 90th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Spokane Valley
- Scott SmithSpokane Valley$9K
- William WerschlerSpokane$5.1M
- Clive LiuBellevue$3.3M
- Katherine ReedSpokane$3.1M
- Morrisa BaskinWenatchee$1.1M
- Vivian ShiSeattle$1.1M
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Michi ShinoharaSeattle$277K
- Andrew PaceTacoma$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.